Cardiff Oncology Inc. buy DrMabuse
Start price
19.09.20
/
50%
€7.40
Target price
29.09.20
-
Performance (%)
72.97%
End price
29.09.20
€12.80
Summary
This prediction ended on 29.09.20 with a price of €12.80. With a performance of 72.97% the BUY prediction by DrMabuse was a big success. DrMabuse has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cardiff Oncology Inc. | -5.274% | -5.274% | 87.099% | -59.741% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
According to DrMabuse what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Cons
High risks for its business
Comments by DrMabuse for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.
In the thread Trading Trovagene
Buy beendet
Stopped prediction by DrMabuse for Cardiff Oncology Inc.
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€4.94
06.09.20
06.09.20
-
19.09.20
19.09.20
49.80%
19.09.20
19.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.34
03.09.20
03.09.20
-
03.09.20
03.09.20
-
03.09.20
03.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€6.65
22.08.20
22.08.20
-
03.09.20
03.09.20
-11.28%
03.09.20
03.09.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€5.40
08.08.20
08.08.20
-
21.08.20
21.08.20
23.15%
21.08.20
21.08.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.80
25.07.20
25.07.20
-
08.08.20
08.08.20
42.11%
08.08.20
08.08.20
High risks for its business
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.06
14.06.20
14.06.20
-
27.06.20
27.06.20
111.65%
27.06.20
27.06.20
High risks for its business